Management of Atrial Fibrillation with Rapid Ventricular Response in Patients with Reduced Ejection Fraction
First-Line Treatment Options for AFib RVR with Reduced Ejection Fraction
- The European Society of Cardiology recommends beta-blockers as the first-line agents for rate control in patients with atrial fibrillation and reduced ejection fraction (LVEF <40%) 1, 2
- The smallest effective dose of beta-blocker should be used to achieve rate control in patients with heart failure, with options including metoprolol, esmolol, or propranolol at appropriate doses 3, 4
- Amiodarone is an alternative option for patients with hemodynamic instability or severely reduced LVEF who cannot tolerate beta-blockers 3
Treatment Considerations to Avoid Worsening Heart Failure
- Non-dihydropyridine calcium channel blockers (diltiazem, verapamil) should be avoided in patients with reduced left ventricular function (LVEF ≤40%) due to their negative inotropic effects 2, 3
- The European Society of Cardiology explicitly recommends against diltiazem in patients with LVEF <40% as it may worsen heart failure 1, 3
Monitoring and Adjusting Therapy
- Initial resting heart rate target should be <110 bpm, and echocardiogram should be performed to determine further management and choice of maintenance therapy 3
- Avoid bradycardia and consider need for anticoagulation based on CHA₂DS₂-VA score 1, 3
Practical Considerations for Long-Term Management
- Regular reassessment of LVEF is recommended to guide therapy adjustments, and consideration of the four cornerstone medications for heart failure with reduced EF (beta-blockers, ACE inhibitors/ARBs, mineralocorticoid receptor antagonists, and SGLT2 inhibitors) is advised 6
- When using beta-blockers, start with low doses and titrate carefully to avoid hypotension and bradycardia, and avoid discontinuing heart failure medications inappropriately 5, 6